Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice

Journal of Experimental Medicine

Volumn 184, Issue 6, 1996, Pages 2261-2269

  Hege, Kristen M ^a   Cooke, Keegan S ^a   Finer, Mitchell H ^a   Zsebo, Krisztina M ^a   Roberts, Margo R ^a  

^a CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; TUMOR IMMUNOLOGY;

ANIMALS; ANTIGENS, CD4; BONE MARROW TRANSPLANTATION; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; FEMALE; GENE PRODUCTS, ENV; GRAFT SURVIVAL; HIV; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, SCID; NEUTROPHILS; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030471705     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.6.2261     Document Type: Article

References (51)

1. Baltimore, D. 1988. Intracellular immunization. Nature (Lond.). 335:395-396.
2. Gilboa, E., and E. Smith. 1994. Gene therapy for infectious diseases: the AIDS model. Trends Genet. 10:139-144.
3. Bridges, S.H., and N. Sarver. 1995. Gene therapy and immune restoration for HIV disease. Lancet. 345:427-432.
4. Lever, A.M. 1995. Gene therapy for HIV infection. Br. Med. Bull. 51:149-166.
5. + CTL in vivo with peptide vaccine constructs. J. Immunol. 152:549-556.
6. Laube, L.S., M. Burrascano, C.E. Dejesus, B.D. Howard, M.A. Johnson, W.T. Lee, A.E. Lynn, G. Peters, G.S. Ronlov, and K.S. Townsend. 1994. Cytotoxic T lympocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency type-1 IIIB ENV/REV proteins. Hum. Gene Ther. 5:853-862.
7. Tepper, R.I., and J.J. Mule. 1994. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther. 5:153-164.
8. Culver, K.W., T.M. Vickers, J.L. Lamsam, and T. Walling. 1995. Gene therapy for solid tumors. Br. Med. Bull. 51:192-204.
9. Irving, B.A., and A. Weiss. 1991. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways. Cell. 64:891-901.
10. Romeo, C., and B. Seed. 1991. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell. 64:1037-1046.
11. Letourneur, F., and R.D. Klausner. 1991. T-cell and basophil activation through the cytoplasmic tail of T-cell receptor ζ family proteins. Proc. Natl. Acad. Sci. USA. 88:8905-8909.
12. Hwu, P., G.E. Shafer, J. Treisman, D.G. Schindler, G. Gross, R. Cowher, S.A. Rosenberg, and Z. Eshhar. 1993. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor γ chain. J. Exp. Med. 178:361-366.
13. + T lymphocytes armed with universal T-cell receptors. Blood. 84:2878-2889.
14. Tran, A.-C., D. Zhang, R. Byrn, and M.R. Roberts. 1994. Chimeric ζ-receptors direct human natural killer effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes. J. Immunol. 155:1000-1009.
15. Sussman, J.J., J.S. Bonifacino, J. Lippincott-Schwartz, A.M. Weissman, T. Saito, R.D. Klausner, and J.D. Ashwell. 1988. Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex. Cell. 52:85-95.
16. Frank, S.J., B.B. Niklinska, D.G. Orloff, M. Mercep, J.D. Ashwell, and R.D. Klausner. 1990. Structural mutations of the T cell receptor zeta chain and its role in T cell activation. Science (Wash. DC). 249:174-177.
17. Kuster, H., H. Thompson, and J.-P. Kinet. 1990. Characterization and expression of the gene for the human Fc receptor γ subunit. J. Biol. Chem. 265:6448-6452.
18. Kinet, J.-P. 1992. The γ-ζ dimers of Fc receptors as connectors to signal transduction. Curr. Opin. Immunol. 4:43-48.
19. Letourneur, O., I.C.S. Kennedy, A.T. Brini, J.R. Ortaldo, J.J. O'Shea, and J.-P. Kinet. 1991. Characterization of the family of dimers associated with Fc receptors (FcεRI and FcγRIII). J. Immunol. 147:2652-2656.
20. Vivier, E., M. Ackerly, N. Rochet, and P. Anderson. 1992. Structure and function of the CD16:ζ:γ complex expressed on human natural-killer cells. Int. J. Cancer(Suppl.)7:11-14.
21. Wirthmueller, U., T. Kurosaki, M.S. Murakami, and J.V. Ravetch. 1992. Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain. J. Exp. Med. 175: 1381-1390.
22. Bosma, G.C., R.P. Custer, and M.J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature (Lond.). 301:527-530.
23. Bosma, M.J., and A.M. Carroll. 1991. The SCID mouse mutant: definition, characterization, and potential uses. Annu. Rev. Immunol. 9:325-350.
24. Finer, M.H., T.J. Dull, L. Qin, D. Parson, and M.R. Roberts. 1994. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood. 83:43-50.
25. Cavacini, L.A., C.L. Emes, J. Power, J. Underdahl, R. Goldstein, K. Mayer, and M.R. Posner. 1993. Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression. J. Acquir. Immune Defic. Syndr. 6:1093-1102.
26. Cattan, A.R., and E. Douglas. 1993. The C.B.17 SCID mouse strain as a model for human disseminated leukaemia and myeloma in vivo. Leuk. Res. 18:513-522.
27. Moritz, T., V.P. Patel, and D.A. Williams. 1994. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J. Clin. Invest. 93:1451-1457.
28. Ferrante, A., and Y.H. Thong. 1980. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human peripheral blood by the Ficoll-Hypaque method. J. Immunol. Methods. 36:109-117.
29. Lim, B., D.A. Williams, and S.H. Orkin. 1987. Retrovirus-mediated gene transfer of human adenosine deaminase: expression of functional enzyme in murine hematopoietic stem cells in vivo. Mol. Cell. Biol. 7:3459-3465.
30. Lerner, C., and D.E. Harrison. 1990. 5-Fluorouracil spares hematopoietic stem cells responsible for long-term repopulation. Exp. Hematol. 18:114-118.
31. Ho, M., and T.A. Springer. 1983. Tissue distribution, structural characterization, and biosynthesis of Mac-3, a macrophage surface glycoprotein exhibiting molecular weight heterogeneity. J. Biol. Chem. 258:636-642.
32. Spangrude, G.J., S. Heimfeld, and I.L. Weissman. 1991. Purification and characterization of mouse hematopoietic stem cells. Science (Wash. DC). 241:58-62.
33. Sentman, C.I. J. Hackett, V. Kumar, and M. Bennett. 1989. Identification of a subset of murine natural killer cells that mediates rejection of Hh-1b bone marrow grafts. J. Exp. Med. 170:191-202.
34. Uchida, N., W.H. Fleming, E.J. Alpern, and I.L. Weissman. 1993. Heterogeneity of hematopoietic stem cells. Curr. Opin. Immunol. 5:177-184.
35. Mager, D., and P. Henthron. 1984. Identification of a retrovirus-like repetitive element in human DNA. Proc. Natl. Acad. Sci. USA. 81:7510-7514.
36. Brodsky, I. 1993. Expression of HERV-K proviruses in human leukocytes. Blood. 81:2369-2374.
37. Baldwin, G.C., G.Y. Chung, C. Kaslander, T. Esmail, R.A. Reisfeld, and D.W. Golde. 1993. Colony-stimulating factor enhancement of myeloid cell cytotoxicity towards neuroectodermal tumour cells. Br. J. Haematol. 83:545-553.
38. Valerius, T., R. Repp, T.P.M. de Wit, S. Berthold, E. Platzer, J.R. Kalden, M. Gramatzki, and J.G.J. van de Winkel. 1993. Involvement of the high affinity receptor for IgG (FrγRI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood. 82:931-939.
39. Reali, E., A.L. Guiliani, S. Spisani, S. Moretti, R. Gavioli, G. Masucci, R. Gambari, and S. Traniello. 1994. Interferon-γ enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16. Clin. Immunol. Immunopathol. 71:105-112.
40. Ernst, L.K., J.F. Van der Winkle, I.M. Chiu, and C.L. Anderson. 1992. Three genes for the human high affinity Fc receptor for IgG (FcγRI) encode four distinct transcription products. J. Biol. Chem. 267:15692-15700.
41. Scholl, P.R., and R.S. Geha. 1993. Physical association between the high affinity IgG receptor (Fc gamma RI) and the gamma subunit of the high affinity IgE receptor (Fc epsilon RI gamma). Proc. Natl. Acad. Sci. USA. 90:8847-8850.
42. Paolini, R., V. Renard, E. Vivier, K. Ochiai, M.H. Jouvin, B. Malissen, and J.P. Kinet. 1995. Different roles for the Fc epsilon RI gamma chain as a function of the receptor context. J. Exp. Med. 181:247-255.
43. Jewett, A., J.V. Giorgi, and B. Bonavida. 1990. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients. J. Immunol. 145:4065-4071.
44. Szelc, C.M., C. Mitcheltree, R.L. Roberts, and E.R. Stiehm. 1992. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection. J. Infect. Dis. 166:486-493.
45. Mufson, R.A., J. Aghajanian, G. Wong, C. Woodhouse, and A.C. Morgan. 1989. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell. Immunol. 119:182-192.
46. Young, D.A., L.D. Lowe, and S.C. Clark. 1990. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. J. Immunol. 145:607-615.
47. Ragnhammar, P., J.E. Frodin, P.P. Trotta, and H. Mellstedt. 1994. Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor, and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Cancer Immunol. Immunother. 39: 254-262.
48. Bonnema, J.D., L.M. Karnitz, R.A. Schoon, R.T. Abraham, and P.J. Leibson. 1994. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J. Exp. Med. 180:1427-1435.
49. Brenner, M.K., J.M. Cunningham, B.P. Sorrentino, and H.E. Heslop. 1995. Gene transfer into hemopoietic progenitor cells. Br. Med. Bull. 51:167-191.
50. Yu, M., M.C. Leavitt, M. Maruyama, O. Yamada, D. Young, A.D. Ho, and F. Wong-Staal. 1995. Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 92:699-703.
51. Murphy, W.J., S.K. Durum, M.R. Anver, D.K. Ferris, D.W. McVicar, J.J. O'Shea, S.K. Ruscetti, M.R. Smith, H.A. Young, and D.L. Longo. 1994. Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). J. Immunol. 153: 1004-1014.